Embotelladora Andina S.A. (AKO.A)
NYSE: AKO.A · Real-Time Price · USD
19.99
+1.27 (6.78%)
Aug 13, 2025, 10:06 AM - Market open

Akoya Biosciences Revenue

Embotelladora Andina had revenue of 738.15B CLP in the quarter ending June 30, 2025, with 9.81% growth. This brings the company's revenue in the last twelve months to 3.35T, up 21.71% year-over-year. In the year 2024, Embotelladora Andina had annual revenue of 3.22T with 23.14% growth.

Revenue (ttm)
3,351.17B CLP
Revenue Growth
+21.71%
P/S Ratio
0.93
Revenue / Employee
207,284,891 CLP
Employees
16,167
Market Cap
3.36B USD

Revenue Chart

* This company reports financials in CLP.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243,224.23B605.80B23.14%
Dec 31, 20232,618.44B-38.44B-1.45%
Dec 31, 20222,656.88B440.15B19.86%
Dec 31, 20212,216.73B518.45B30.53%
Dec 31, 20201,698.28B-80.74B-4.54%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition